RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Asian Phytoceuticals PCL Stock

Asian Phytoceuticals PCL Revenue 2024

Asian Phytoceuticals PCL Revenue

292.76 M THB

Ticker

APCO.BK

ISIN

TH1077A10Z09

In 2024, Asian Phytoceuticals PCL's sales reached 292.76 M THB, a 16.93% difference from the 250.38 M THB sales recorded in the previous year.

The Asian Phytoceuticals PCL Revenue history

YEARREVENUE (undefined THB)GROSS MARGIN (%)
2023292.7680,45
2022250.3880,85
2021223.3579,29
2020247.7378,66
2019247.6579,08
2018369.8382,45
2017415.7483,77
2016421.3885,86
2015409.2584,13
2014425.8183,62
2013348.583,24
201228683,71
2011290.781,70
2010255.778,69
2009290.779,77
2008140.480,34
200755.675,18

Asian Phytoceuticals PCL Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Asian Phytoceuticals PCL, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Asian Phytoceuticals PCL from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Asian Phytoceuticals PCL’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Asian Phytoceuticals PCL. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Asian Phytoceuticals PCL’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Asian Phytoceuticals PCL’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Asian Phytoceuticals PCL’s growth potential.

Asian Phytoceuticals PCL Revenue, EBIT and net profit per share

DateAsian Phytoceuticals PCL RevenueAsian Phytoceuticals PCL EBITAsian Phytoceuticals PCL Net Income
2023292.76 M undefined116.89 M undefined107.49 M undefined
2022250.38 M undefined88.03 M undefined80.92 M undefined
2021223.35 M undefined73.82 M undefined68.7 M undefined
2020247.73 M undefined75.53 M undefined69.98 M undefined
2019247.65 M undefined65.58 M undefined57.9 M undefined
2018369.83 M undefined116.76 M undefined94.75 M undefined
2017415.74 M undefined131.08 M undefined108.21 M undefined
2016421.38 M undefined137.46 M undefined131.42 M undefined
2015409.25 M undefined125.72 M undefined100.62 M undefined
2014425.81 M undefined147.92 M undefined118.77 M undefined
2013348.5 M undefined104.2 M undefined78.8 M undefined
2012286 M undefined72.1 M undefined55.1 M undefined
2011290.7 M undefined71.3 M undefined50.2 M undefined
2010255.7 M undefined61.4 M undefined44.3 M undefined
2009290.7 M undefined79.3 M undefined54.4 M undefined
2008140.4 M undefined27.9 M undefined20.1 M undefined
200755.6 M undefined-300,000 undefined-1.5 M undefined

Asian Phytoceuticals PCL stock margins

The Asian Phytoceuticals PCL margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Asian Phytoceuticals PCL. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Asian Phytoceuticals PCL.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Asian Phytoceuticals PCL's sales revenue. A higher gross margin percentage indicates that the Asian Phytoceuticals PCL retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Asian Phytoceuticals PCL's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Asian Phytoceuticals PCL's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Asian Phytoceuticals PCL's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Asian Phytoceuticals PCL. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Asian Phytoceuticals PCL's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Asian Phytoceuticals PCL Margin History

Asian Phytoceuticals PCL Gross marginAsian Phytoceuticals PCL Profit marginAsian Phytoceuticals PCL EBIT marginAsian Phytoceuticals PCL Profit margin
202380.45 %39.93 %36.72 %
202280.85 %35.16 %32.32 %
202179.29 %33.05 %30.76 %
202078.66 %30.49 %28.25 %
201979.08 %26.48 %23.38 %
201882.45 %31.57 %25.62 %
201783.77 %31.53 %26.03 %
201685.86 %32.62 %31.19 %
201584.13 %30.72 %24.59 %
201483.62 %34.74 %27.89 %
201383.24 %29.9 %22.61 %
201283.71 %25.21 %19.27 %
201181.7 %24.53 %17.27 %
201078.69 %24.01 %17.32 %
200979.77 %27.28 %18.71 %
200880.34 %19.87 %14.32 %
200775.18 %-0.54 %-2.7 %

Asian Phytoceuticals PCL Aktienanalyse

What does Asian Phytoceuticals PCL do?

Asian Phytoceuticals PCL ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Asian Phytoceuticals PCL's Sales Figures

The sales figures of Asian Phytoceuticals PCL originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Asian Phytoceuticals PCL’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Asian Phytoceuticals PCL's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Asian Phytoceuticals PCL’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Asian Phytoceuticals PCL stock

How much revenue did Asian Phytoceuticals PCL generate this year?

Asian Phytoceuticals PCL has achieved a revenue of 292.76 M THB this year.

How much was the turnover of the company Asian Phytoceuticals PCL compared to the previous year?

The revenue of Asian Phytoceuticals PCL has increased by 16.93% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Asian Phytoceuticals PCL?

The revenue of Asian Phytoceuticals PCL is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Asian Phytoceuticals PCL measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Asian Phytoceuticals PCL so important for investors?

The revenue of Asian Phytoceuticals PCL is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Asian Phytoceuticals PCL pay?

Over the past 12 months, Asian Phytoceuticals PCL paid a dividend of 0.16 THB . This corresponds to a dividend yield of about 2.77 %. For the coming 12 months, Asian Phytoceuticals PCL is expected to pay a dividend of 0.16 THB.

What is the dividend yield of Asian Phytoceuticals PCL?

The current dividend yield of Asian Phytoceuticals PCL is 2.77 %.

When does Asian Phytoceuticals PCL pay dividends?

Asian Phytoceuticals PCL pays a quarterly dividend. This is distributed in the months of May, May, June, May.

How secure is the dividend of Asian Phytoceuticals PCL?

Asian Phytoceuticals PCL paid dividends every year for the past 12 years.

What is the dividend of Asian Phytoceuticals PCL?

For the upcoming 12 months, dividends amounting to 0.16 THB are expected. This corresponds to a dividend yield of 2.77 %.

In which sector is Asian Phytoceuticals PCL located?

Asian Phytoceuticals PCL is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Asian Phytoceuticals PCL kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Asian Phytoceuticals PCL from 5/13/2024 amounting to 0.18 THB, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.

When did Asian Phytoceuticals PCL pay the last dividend?

The last dividend was paid out on 5/13/2024.

What was the dividend of Asian Phytoceuticals PCL in the year 2023?

In the year 2023, Asian Phytoceuticals PCL distributed 0.123 THB as dividends.

In which currency does Asian Phytoceuticals PCL pay out the dividend?

The dividends of Asian Phytoceuticals PCL are distributed in THB.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Asian Phytoceuticals PCL

Our stock analysis for Asian Phytoceuticals PCL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Asian Phytoceuticals PCL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.